Molecular heterogeneity in diffuse large B-cell lymphoma and its implications in clinical diagnosis and treatment
Author:
Funder
Fujian Province Natural Fund
Training Project for Young and Middle-Aged Talents of Fujian Provincial Department of Health in China
Publisher
Elsevier BV
Subject
Cancer Research,Genetics,Oncology
Reference150 articles.
1. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications;Campo;Blood,2011
2. R-CHOP therapy alone in limited stage diffuse large B-cell lymphoma;Tomita;Br. J. Haematol.,2013
3. Genetic heterogeneity of diffuse large B-cell lymphoma;Zhang;Proc. Natl. Acad. Sci. U. S. A.,2013
4. A microarray platform-independent classification tool for cell of origin class allows comparative analysis of gene expression in diffuse large B-cell lymphoma;Care;PLoS One,2013
5. Gene expression profiling of diffuse large B-cell lymphomas supervised by CD5 expression;Miyazaki;Int. J. Hematol.,2015
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Non-neoplastic cells as prognostic biomarkers in diffuse large B-cell lymphoma: A system review and meta-analysis;Tumori Journal;2024-01-05
2. Long non-coding RNA SNHG17 may function as a competitive endogenous RNA in diffuse large B-cell lymphoma progression by sponging miR-34a-5p;PLOS ONE;2023-11-21
3. Prognostic impact of absolute peripheral blood NK cell count after four cycles of R-CHOP-like regimen treatment in patients with diffuse large B cell lymphoma;Clinical and Experimental Medicine;2023-11-08
4. Meta-Analysis of MS-Based Proteomics Studies Indicates Interferon Regulatory Factor 4 and Nucleobindin1 as Potential Prognostic and Drug Resistance Biomarkers in Diffuse Large B Cell Lymphoma;Cells;2023-01-03
5. The genetic deletion and protein expression of PRDM1 and its clinical implications in diffuse large B cell lymphoma: A retrospective cohort study in China;Pathology - Research and Practice;2022-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3